Inhibition of monoamine oxidase by sodium pentobarbital.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D003864:Depression, Chemical; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors; D009206:Myocardium / Q000201:enzymology*; D010101:Oxygen Consumption; D010424:Pentobarbital / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013053:Spectrophotometry; D013997:Time Factors; D014466:Ultraviolet Rays
D008996:Monoamine Oxidase Inhibitors; D012964:Sodium; D010424:Pentobarbital